Report
David Seynnaeve, PhD

Onward Medical NV - Our view on Neuralink's BCI update

*Yesterday we saw ONWD's share price surge (+ >20%) following Neuralink announcing the first human implant of its wireless brain chip 'Telepathy'.*Based on ONWD mgmt's feedback, we don't see Neuralink as a threat for ONWD for now as 1/ companies focus on different application areas, 2/ lack of data supporting mobility improvement, 3/ invasiveness of Neuralink's tech, and 4/ ONWD's restrictive IP especially in the area of arm & hand mobility post-spinal cord injury (SCI).*Buy rating reiterated.
Underlying
ONWARD MEDICAL NV

Provider
Degroof Petercam
Degroof Petercam

​We are an investment house with Belgian roots founded on more than 150 years of trust.

As a private company owned by long-term committed shareholders, we are independent. Naturally and structurally. Our experts have the knowledge to think and act without bias, and to make decisions that benefit our clients. Today and tomorrow.

Analysts
David Seynnaeve, PhD

Other Reports on these Companies
Other Reports from Degroof Petercam

ResearchPool Subscriptions

Get the most out of your insights

Get in touch